Calligonum comosum (Escanbil) extract exerts anti-angiogenic, anti-proliferative and anti-inflammatory effects on endometriotic lesions
article
OA: closed
CC0
⤵ 8 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
Calligonum comosum extract demonstrated anti-angiogenic, anti-proliferative, and anti-inflammatory effects on endometriotic lesions in this study.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (57)
- Advances in the management of endometriosis: an update for clinicians via openalex
- Anti-angiogenic treatment strategies for the therapy of endometriosis via openalex
- Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis via openalex
- Basic mechanisms of vascularization in endometriosis and their clinical implications via openalex
- Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor- by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions via openalex
- Effect of the estrus cycle stage on the establishment of murine endometriosis lesions via openalex
- Endometriosis and angiogenesis. via openalex
- Evolution of medical treatment for endometriosis: back to the roots? via openalex
- Growth mechanisms of endometriotic cells in implanted places: a review via openalex
- High-Resolution Ultrasound Imaging via openalex
- Immunohistochemical characterization of leucocyte subpopulations in endometriotic lesions via openalex
- Inflammation and endometriosis via openalex
- Inflammation and nerve fiber interaction in endometriotic pain via openalex
- Laparoscopic surgery for endometriosis: How often do we need to re-operate? via openalex
- Mouse Model of Surgically-induced Endometriosis by Auto-transplantation of Uterine Tissue via openalex
- Mouse Model of Surgically-induced Endometriosis by Auto-transplantation of Uterine Tissue via openalex
- Natural therapies assessment for the treatment of endometriosis via openalex
- Pathogenesis and pathophysiology of endometriosis via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Resveratrol is a potent inhibitor of vascularization and cell proliferation in experimental endometriosis via openalex
- Size and spatial orientation of uterine tissue transplants on the peritoneum crucially determine the growth and cyst formation of endometriosis-like lesions in mice via openalex
- The peritoneal environment in endometriosis via openalex
- Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. via openalex
- W2311972351 via openalex
- W2313308273 via openalex
- W2317751349 via openalex
- W2473502467 via openalex
- W2508826573 via openalex
- W2754055756 via openalex
- W2905850087 via openalex
- W4211081176 via openalex
- W6601830869 via openalex
- W6666980266 via openalex
- W6679537468 via openalex
- W6698455570 via openalex
- W1579436033 via openalex
- W1895381846 via openalex
- W1916800927 via openalex
- W1926681914 via openalex
- W1985645379 via openalex
- W1996848457 via openalex
- W2006175781 via openalex
- W2006760151 via openalex
- W2007546842 via openalex
- W2021683285 via openalex
- W2032247674 via openalex
- W2038972387 via openalex
- W2072483235 via openalex
- W2100070858 via openalex
- W2130539656 via openalex
- W2135414744 via openalex
- W2137773942 via openalex
- W2139102923 via openalex
- W2148242909 via openalex
- W2157708842 via openalex
- W2181482436 via openalex
- W2289950134 via openalex
Cited by (8)
- Natural bioactive compounds and herbal medicines targeting common signaling pathways in endometriosis: mechanisms and therapeutic implications 2025
- The ischemic time window of ectopic endometrial tissue crucially determines its ability to develop into endometriotic lesions 2022
- Effect of Neiyi Prescription of QIU on autophagy and angiogenic ability of endometriosis via the PPARγ/NF-κB signaling pathway 2022
- Differences in growth and vascularization of ectopic menstrual and non-menstrual endometrial tissue in mouse models of endometriosis 2021
- Targeting sphingosine kinase‐1 with the low MW inhibitor SKI‐5C suppresses the development of endometriotic lesions in mice 2021
- Plants as source of new therapies for endometriosis: a review of preclinical and clinical studies 2020
- Sodium tanshinone IIA sulfonate restrains fibrogenesis through induction of senescence in mice with induced deep endometriosis 2020
- Endometriosis – a decade later – still an enigmatic disease. What is the new in the diagnosis and treatment? 2019
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:22:48.502547+00:00
License: CC0
· commercial use OK